About ORCA-3: A Clinical Study of Cytisinicline as a New Treatment Option to Help Adults Quit Smoking
The ORCA-3 study is being conducted to learn more about the effectiveness and safety of an oral medicine, cytisinicline, in combination with behavioral support in people trying to quit cigarette smoking.
Precision Clinical ResearchJune 12, 2022
